TG p.Cys1996Ser
Variant summary
Our verdict is Pathogenic. The variant received 10 ACMG points: 10P and 0B. PS1PM2PP3_Strong
The NM_003235.5(TG):c.5987G>C(p.Cys1996Ser) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another nucleotide change resulting in the same amino acid substitution has been previously reported as Pathogenic in ClinVar.
Frequency
Consequence
NM_003235.5 missense
Scores
Clinical Significance
Conservation
Publications
- thyroid dyshormonogenesis 3Inheritance: AR Classification: STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae)
- familial thyroid dyshormonogenesisInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- thyroid cancerInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 10 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_003235.5. You can select a different transcript below to see updated ACMG assignments.
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| TG | TSL:1 MANE Select | c.5987G>C | p.Cys1996Ser | missense | Exon 33 of 48 | ENSP00000220616.4 | P01266-1 | ||
| TG | TSL:1 | n.*2200G>C | non_coding_transcript_exon | Exon 20 of 35 | ENSP00000428628.1 | H0YB42 | |||
| TG | TSL:1 | n.*2200G>C | 3_prime_UTR | Exon 20 of 35 | ENSP00000428628.1 | H0YB42 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 29
GnomAD4 genome Cov.: 32
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.